View in EDS HTML Full Text PDF Full Text

The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer.
Authors: Divoux, Jordane1,2,3 (AUTHOR), Florent, Romane1,2,3 (AUTHOR), Jacobs, Margaux4 (AUTHOR), Lequesne, Justine5 (AUTHOR), Grellard, Jean-Michel5 (AUTHOR), San, Chankannira5 (AUTHOR), Grossi, Sara5 (AUTHOR), Kerdja, Katia5 (AUTHOR), Clarisse, Bénédicte5 (AUTHOR), Boudier, Gwenaelle5 (AUTHOR), Cherifi, François4 (AUTHOR), Briand, Mélanie1,6 (AUTHOR), Dolivet, Enora1,7 (AUTHOR), Johnson, Alisson4,5 (AUTHOR), Dubois, Brice8 (AUTHOR), Harter, Valentin8 (AUTHOR), Lacroix, Joëlle9 (AUTHOR), Raboutet, Charlotte9 (AUTHOR), Marie, Brigitte9 (AUTHOR), Rousseau, Nathalie2,10 (AUTHOR)
Source: BMC Cancer. 9/19/2023, Vol. 23 Issue 1, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-023-11362-8